Lv4
610 积分 2024-01-09 加入
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy
8天前
已完结
Drugging the Next Undruggable KRAS Allele-Gly12Asp
15天前
已完结
Identification of Novel Series of Potent and Selective Relaxin Family Peptide Receptor 1 (RXFP1) Agonists
1个月前
已完结
Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist
1个月前
已完结
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
1个月前
已完结
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
1个月前
已完结
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition
1个月前
已完结
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
2个月前
已完结
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
2个月前
已完结
Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor
3个月前
已完结
皖公网安备34019202002308
